TaiwanJ Pharmaceuticals Co's quarterly market cap
declined
from Dec. 2024 (NT$650.59 Mil) to Jun. 2025 (NT$624.95 Mil) and
declined
from Jun. 2025 (NT$624.95 Mil) to Dec. 2025 (NT$618.54 Mil).
TaiwanJ Pharmaceuticals Co's annual market cap
declined
from Dec. 2023 (NT$1,089.27 Mil) to Dec. 2024 (NT$650.59 Mil) and
declined
from Dec. 2024 (NT$650.59 Mil) to Dec. 2025 (NT$618.54 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. TaiwanJ Pharmaceuticals Co's Enterprise Value for Today is NT$505.23 Mil.
TaiwanJ Pharmaceuticals Co (ROCO:6549) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
TaiwanJ Pharmaceuticals Co Market Cap Related Terms
TaiwanJ Pharmaceuticals Co Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6549 vs VRTX, REGN, ALNY: Market Cap Comparison
For the Biotechnology subindustry, TaiwanJ Pharmaceuticals Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TaiwanJ Pharmaceuticals Co Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, TaiwanJ Pharmaceuticals Co's Market Cap distribution charts can be found below:
* The bar in red indicates where TaiwanJ Pharmaceuticals Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TaiwanJ Pharmaceuticals Co (ROCO:6549) has a Market Cap of NT$571.27 Mil as of Jul. 05, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on TaiwanJ Pharmaceuticals Co and its competitors. According to the industry distribution chart, TaiwanJ Pharmaceuticals Co ranks #1114 out of 1422 companies in the Biotechnology industry, placing it in the top 78.3%.
Is TaiwanJ Pharmaceuticals Co's Market Cap too high?
TaiwanJ Pharmaceuticals Co's current Market Cap is NT$571.27 Mil. Based on the distribution chart, TaiwanJ Pharmaceuticals Co ranks #1114 out of 1422 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, TaiwanJ Pharmaceuticals Co has a GF Score™ of 42/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does TaiwanJ Pharmaceuticals Co's Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, TaiwanJ Pharmaceuticals Co ranks #1114 out of 1422 companies for Market Cap. This places TaiwanJ Pharmaceuticals Co in the lower half of its industry. The industry median Market Cap is 121.26. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 121.26, based on 1,422 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on TaiwanJ Pharmaceuticals Co and its competitors. For the Biotechnology industry, the median Market Cap is 121.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TaiwanJ Pharmaceuticals Co's current Market Cap is NT$571.27 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TaiwanJ Pharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, TaiwanJ Pharmaceuticals Co (ROCO:6549) is currently considered Possible Value Trap. The stock's GF Value™ is NT$11.94, compared to a current price of NT$7.13 — trading 40.3% below its estimated fair value. The current Market Cap is NT$571.27 Mil. TaiwanJ Pharmaceuticals Co's overall GF Score™ is 42/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For TaiwanJ Pharmaceuticals Co (ROCO:6549), the current Market Cap is NT$571.27 Mil as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TaiwanJ Pharmaceuticals Co (ROCO:6549) Overvalued in 2026?
Based on GuruFocus' analysis, TaiwanJ Pharmaceuticals Co stock appears to be undervalued.
The current stock price of NT$7.13 is trading 40.3% below its estimated GF Value™ of NT$11.94.
GuruFocus considers TaiwanJ Pharmaceuticals Co to be Possible Value Trap.
Key valuation signals for ROCO:6549:
Market Cap: NT$571.27 Mil
GF Value™: NT$11.94 vs. price of NT$7.13 (40.3% below fair value)
No single metric tells the full story. See the ROCO:6549 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TaiwanJ Pharmaceuticals Co Ltd is a Taiwan based specialty pharmaceutical company focused on small molecules for unmet medical needs like chronic organ inflammation of metabolic, autoimmune and infectious etiologies. It is also involved in developing novel chemical entities (NCEs) for chronic liver diseases and allergy/asthma.
42GF Score
Get the complete analysis for ROCO:6549
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6549 has been successfully added to your 
